Booth et al., 1971 - Google Patents
Food preferences acquired by association with variations in amino acid nutritionBooth et al., 1971
- Document ID
- 4662957815085698313
- Author
- Booth D
- Simson P
- Publication year
- Publication venue
- The Quarterly journal of experimental psychology
External Links
Snippet
Protein-deprived rats were given, on one day, a balanced mixture of amino acids followed by access to protein-free food having a distinctive odour. On another day, an imbalanced (histidine-free) amino acid mixture was given just before food having another odour. The rats …
- 150000001413 amino acids 0 title abstract description 60
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic, hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
- A61K31/197—Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl group being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid, pantothenic acid
- A61K31/198—Alpha-aminoacids, e.g. alanine, edetic acids [EDTA]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic, hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
- A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
- A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Booth et al. | Food preferences acquired by association with variations in amino acid nutrition | |
| Ziegler, MD et al. | Strategies for attenuating protein-catabolic responses in the critically ill | |
| Barbezat et al. | The exocrine pancreas and protein-calorie malnutrition | |
| Furukawa et al. | Supplemental glutamine augments phagocytosis and reactive oxygen intermediate production by neutrophils and monocytes from postoperative patients in vitro | |
| Kreider et al. | Effects of ingesting protein with various forms of carbohydrate following resistance-exercise on substrate availability and markers of anabolism, catabolism, and immunity | |
| US5900435A (en) | Composition, food product and uses of 3-guanidinopropionic acid | |
| DE60212693T2 (en) | FORMULATION OF AMINO ACIDS AND RIBOFLAVIN TO REDUCE THE TOXIC EFFECTS OF CYTOTOXIC CHEMOTHERAPY | |
| KR970005330B1 (en) | Nuitrition for persons infected with human immuno deficieny virus | |
| Dukkipati et al. | Is there a role for intradialytic parenteral nutrition? A review of the evidence | |
| DE3785667T2 (en) | ADDITIONAL FOOD OR THERAPY FOR PERSONS WITH RISK OR TREATMENT FOR ARTERIOSCLEROTIC VASCULAR, CARDIOVASCULAR AND / OR THROMBOTIC DISEASES. | |
| Burr et al. | Comparison of the effects of total parenteral nutrition, continuous intragastric feeding, and portacaval shunt on a patient with type I glycogen storage disease | |
| JPH05502881A (en) | Uses of arginine as an immunostimulant | |
| US5276018A (en) | Composition comprising amino acids and methods for decreasing muscle breakdown | |
| Bouletreau et al. | Glucose-lipid ratio is a determinant of nitrogen balance during total parenteral nutrition in critically ill patients: a prospective, randomized, multicenter blind trial with an intention-to-treat analysis | |
| Kopple et al. | Nitrogen balance and plasma amino acid levels in uremic patients fed an essential amino acid diet | |
| Jordan et al. | Hunger and satiety in humans during parenteral hyperalimentation | |
| US20060148754A1 (en) | Composition for treating and/or preventing dysfunctions associated with type 2 diabetes mellitus and insulin resistance | |
| JPH04506597A (en) | Decreased postprandial plasma concentrations of large neutral amino acids | |
| RU2045911C1 (en) | Product for enteral nutrition of patients with high metabolic stress "energoplasten" | |
| JPH01500030A (en) | Use of growth hormone for nitrogen retention in hypocaloric conditions | |
| EP0612245A1 (en) | Use of alpha-ketoglutarate | |
| Paluzzi et al. | A prospective randomized study of the optimal source of nonprotein calories in total parenteral nutrition | |
| Krehl | A concept of optimal nutrition | |
| US6008253A (en) | Use of 3-guanidinopropionic acid to increase endurance, stamina and exercise capacity in a mammal | |
| WO1993017670A1 (en) | Reducing post-prandial fluctuations in plasma concentrations of large neutral amino acids (lnaa) |